Inspire Medical Systems (INSP) Cash & Current Investments (2017 - 2026)

Inspire Medical Systems has disclosed Cash & Current Investments across 10 years of filings, most recently posting $283.8 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $283.8 million, down 23.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $283.8 million (down 23.12% YoY), and the FY2025 annual result was $308.3 million, down 30.81% from the prior year.
• Cash & Current Investments came in at $283.8 million for Q1 2026 at Inspire Medical Systems, down from $308.3 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $467.1 million in Q2 2023 to a low of $196.3 million in Q2 2022.
• The 5-year median for Cash & Current Investments is $427.5 million (2022), against an average of $379.1 million.
• Across the five-year window, Cash & Current Investments soared 137.9% in 2023 and tumbled 31.56% in 2025, its largest moves.
• Inspire Medical Systems' Cash & Current Investments stood at $451.4 million in 2022, then gained by 1.99% to $460.4 million in 2023, then decreased by 3.22% to $445.5 million in 2024, then slumped by 30.81% to $308.3 million in 2025, then decreased by 7.93% to $283.8 million in 2026.
• The last three Cash & Current Investments figures came in at $283.8 million (Q1 2026), $308.3 million (Q4 2025), and $322.6 million (Q3 2025), per Business Quant data.